Oxymetazoline Hydrochloride

盐酸羟甲唑啉

Report date: 2026/05/18 20:02:07
NME

Base Information

Drug NameOxymetazoline Hydrochloride
Drug Alias NameOxymetazolinum Hydrochloride盐酸羟间唑啉Oxylin羟间唑啉Oximetazolina Hydrochloride +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor agonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsRosaceaErythemaHyperemia +[7] 
Global Approved IndicationsRosaceaHyperemiaNasal Obstruction
Approved Indications in ChinaNasal Obstruction
Original Approved Country/TerritoryCanada
Original Approved Date1964/12/31
Country/TerritoryCanadaUnited StatesHungary +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLevation Pharma LtdSato Pharmaceutical LtdMayne Pharma Group Ltd +[6] 
Inactive CompaniesSchering-Plough Canada IncActavis IncAllergan Plc +[7] 
Active IndicationsHyperemiaBlepharoptosisNasal Obstruction +[4] 
Inactive IndicationsRosaceaErythemaSpinal Cord Injuries

Other Information

ATC CodeR01AA05R01AB07S01GA04
Related LinksWikipediaDrugBankKEGG